| Darryl F Lesoski, MD, MPH | |
|
550 Munson Ave, Traverse City, MI 49686-3580 | |
| (231) 935-8590 | |
| (231) 935-8597 |
| Full Name | Darryl F Lesoski |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 550 Munson Ave, Traverse City, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134293160 | NPI | - | NPPES |
| DL067262 | Other | MI | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 4301067262 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Darryl F Lesoski, MD, MPH 550 Munson Ave, Traverse City, MI 49686-3580 Ph: (231) 935-8590 | Darryl F Lesoski, MD, MPH 550 Munson Ave, Traverse City, MI 49686-3580 Ph: (231) 935-8590 |
News Archive
Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet.
PBS' NewsHour on Wednesday featured a story on HIV/AIDS in the Ukraine, which has Europe's highest HIV/AIDS rate, increasing fears that the epidemic could spread to neighboring countries. The story focuses on attempts to implement drug substitution therapy programs for injecting drug users and prevent the virus from moving into the general population.
Ethicon, Inc., a worldwide leader in surgical care, announced today the introduction of ETHICON™ OMNEX™ Surgical Sealant, ETHICON™ Biosurgery's first synthetic sealant designed to achieve adjunctive hemostasis (stoppage of bleeding) in vascular reconstructions by mechanically sealing areas of leakage. The US Food and Drug Administration (FDA) recently granted approval of the Premarket Approval Application (PMA) for ETHICON™ OMNEX™ Surgical Sealant.
NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the quarter ended June 30, 2010.
› Verified 2 days ago
David Mcclary, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-935-8590 Fax: 231-935-8597 |